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Background: Influenza vaccination is the most efficient and cost-effective method to prevent influenza. To increase
vaccination coverage, health authorities use various intervention programs (IPs), such as cost subsidies or placing
vaccination centers in malls to make vaccination more accessible. Nevertheless, vaccination coverage has been
sub-optimal in most developed countries, including in Israel.
Methods: To determine possible drivers of individual vaccination uptake and to examine the effectiveness of
different IPs in increasing vaccination, we analyzed a telephone survey of a representative sample of the Israeli
population conducted in March 2011 (n = 470), and paper questionnaires at the work place and at homes during
April-July 2011 to several sub-populations : soldiers (n = 81), medical staff (n = 107), ultra-orthodox Jews (n = 72),
Israeli Arabs (n = 87) and students (n = 85).
Results: The population can be stratified into three sub-groups: Acceptors, who receive vaccination regardless of IPs
(22%), Conditional Acceptors, who are only vaccinated because of IP implementation (44%) and Non-Acceptors, who
are not vaccinated despite IP implementation (34%). Our analysis shows that the risk perception towards influenza
relative to vaccination is higher in the Acceptors than in the Conditional Acceptors, with the Non-Acceptors showing
the lowest risk perception (P < 0.01). For Conditional Acceptors, physician recommendation is the most effective IP,
regardless of the sub-population tested (P = 0.04). Students and low-income participants were more prone than
any others to be persuaded to receive vaccination following IPs. In addition, financial incentives were more effective
for ultra-religious orthodox Jews and students; vaccinations in more accessible areas were more effective for the
ultra-religious orthodox, soldiers, and medical personnel; and TV and radio advertisements were more effective for
people above 50 relative to other age groups.
Conclusions: Risk perception of influenza and vaccination governs the likelihood of successful implementation of
IPs. Policy makers in Israel should invest efforts to increase the knowledge regarding influenza and vaccination,
and should apply specific interventions customized to the preferences and diverse perceptions among the
Israeli sub-populations.
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Influenza has a long history of causing substantial mor-
bidity, mortality, and economic losses [1-3]. In Israel, in-
fluenza is responsible each year for about 801,200
reported infections (around 10% of the population),
4130 hospitalizations, 1140 deaths, 2.7 million work days
lost, and an overall cost to the Israeli economy of 261
million dollars (~0.1 of the GDP) [3,4].
Vaccination is the primary method of preventing influ-
enza infection. Vaccination is beneficial not only for the
vaccinated, but also for the entire population due to re-
duced transmission [2]. Thus, recommendations of both
the US CDC and the Israeli Ministry of Health encourage
all individuals older than six months to be vaccinated. In
particular, as influenza is most prevalent in children under
five, and complications occur predominately in the elderly
and in individuals with co-morbidities [5], vaccination is
highly encouraged among these sub-populations [6].
To increase vaccination rates, authorities and health-
care providers also apply different forms of intervention
programs (IPs). For example, one form of an IP could be
to waive the vaccination fee. Another form could be to
improve accessibility by placing immunization centers in
malls or near work places.
In Israel, since 2008, influenza vaccination is provided
for free to all age groups, and vaccination in the form of
a nasal spray is partly covered [7]. Further, both the
Ministry of Health and health maintenance organiza-
tions invest various efforts to promote vaccination, in
particular, among targeted high-risk populations through
TV, radio advertisements and physician recommenda-
tions. Although vaccination rates are estimated to range
only between 15-20% among the entire population, the
overall vaccination coverage is gradually increasing and
is substantially higher among the targeted high-risk age
groups, with 23-32% in children between six months to
four years, 26-31% in the elderly between 50–65, and
58-63% in individuals above 65 [8]. Nevertheless, influ-
enza vaccination coverage remains sub-optimal in the
majority of developed countries including Israel [6,9,10].
The decision whether or not to be vaccinated is per-
sonal and does not necessarily take into account the wel-
fare of others [11-13]. Health behaviour models suggest
that individuals make their vaccination decisions based on
risk perceptions [14]. From an individual perspective, vac-
cination can be an unpleasant procedure, which demands
time, and, in countries where vaccination is not funded,
money. Several other factors such as religious and personal
beliefs regarding vaccinations, perceived vulnerability, per-
ceived susceptibility, vaccination efficacy, disease severity
[14], effects of worries and regrets [15], vaccine criticism by
media and, sometimes, even by health care workers, all
have been shown to account for the relatively low vaccin-
ation rates [10,16].Earlier studies suggested that the influenza vaccin-
ation decision correlates mainly with vaccination effi-
cacy, disease likelihood, and disease severity relative to
vaccination severity [14,17]. Other studies have focused
on the question of which IPs are most effective at in-
creasing vaccination rates [6,18]. However, to our know-
ledge, no study to date has integrated the relationship
between the effectiveness of IPs on individual vaccin-
ation decisions with their risk perceptions about influ-
enza and vaccination to examine the combined effect on
vaccination rates.
To determine the main drivers for vaccination uptake
and to examine the effectiveness of different IPs in in-
creasing vaccination uptake, we evaluated perceptions of
the Israeli population through a telephone survey of a
representative sample of the Israeli population as well as
through paper questionnaires distributed to sub-groups
of interest. Based on the obtained perception towards in-
fluenza and vaccination, we found that the population
can be divided into three sub-groups: Acceptors who
were vaccinated regardless of IPs, Conditional Acceptors
who were likely to be vaccinated only due to implemen-
tation of IPs, and Non-Acceptors who did not receive
vaccination despite IPs. Specifically, we show that to in-
crease compliance, policy makers should focus mainly
on efforts to increase the knowledge about influenza and
vaccination and apply IPs that are customized to the
preferences of the sub-populations. By helping to im-
prove current IP prioritizations in Israel, our results
stand to inform optimal resource allocation for maximal




The telephone survey was conducted by the B. I. Cohen
Institute for Public Opinion Research in March 2011.
The timing was chosen at the end of the influenza sea-
son to prevent time bias as much as possible [19]. The
questionnaire required short answers and multiple
choice questions whereby all questions were mixed to
prevent order bias in the multiple-choice questions.
The sample included 917 individuals above 18 years of
age from a representative sample of Israeli households.
In order to achieve a representative sample, we used
stratified sampling based on socio-demographic char-
acteristics that included the following: geographic re-
gions, years in the country, levels of religiosity and
socio-economic levels (salary and formal education).
The stratifications were composed according to data
taken from the Israeli Central Bureau of Statistics. The
telephone interview was conducted either in Hebrew,
Russian (to make the sample more representative espe-
cially among older immigrants from the former Soviet
Yamin et al. Israel Journal of Health Policy Research 2014, 3:13 Page 3 of 7
http://www.ijhpr.org/content/3/1/13Union who are not Hebrew speakers), or Arabic. In
cases in which the phone calls were unanswered, poll-
sters repeated calls up to five times within a period of
three weeks. If calls were not successful by the fifth
time, another individual from the same sub-population
was chosen. However, cellular phone numbers were
not included. Out of the 917 interviewees, 83 were un-
reachable after the procedure was initiated. Thus, our
representative sample size contained 834 subjects.
From that sample, 364 refused to participate or did not
fully cooperate leading to 470 interviewees (response
rate 56.7%). Among them, 192 were elderly above 50
years of age, and 244 were parents to children less than
18 years old.
The paper questionnaires for special interest groups
were distributed in person during April-July 2011. The
participants filled the questionnaires while the pollsters
stood by them. The interest groups chosen included a
convenience sample of 81 soldiers who were beyond
their mandatory service (97.6% response rate) serving in
five different bases located in central and southern Israel,
85 students (80.6%) from four different departments
(not related to health studies) at Ben-Gurion University
of the Negev, 107 healthcare workers (61.8%) from two
hospitals and three medical centers, 87 Israeli Arabs
(77.6%) from 8 different towns and 72 ultra-orthodox
Jews (76.5%) from five cities and towns. Being conveni-
ence samples, they may not reflect a representative sam-
ple of each sub-population.Table 1 Intervention programs offered in the survey
study
Number Questionnaire item of the intervention program
1. You will receive the vaccination for free
2. Vaccination will be provided as a nasal spray rather than
a shot
3. You will receive vaccination in a close and more convenient
place, such as a mall or a location near the work place
4. You will receive a $12* coupon to use as you wish in a
pharmacy
5. You will receive $12* if you take the vaccination
6. You will receive information pamphlets regarding the
disease and regarding the vaccination
7. Your family doctor will recommend vaccination
8. TV and radio advertisement will encourage vaccination
9. You will receive a phone call reminder to be vaccinated
10. You will be assessed a health tax of $12 if you do not get
vaccinated
*All prices are translated to U.S. Dollars but originally were presented in the
local currency, New Israeli Shekels (NIS).Procedure
In all surveys, individuals were first asked questions to
determine their perceived risks and hazards due to influ-
enza and vaccination (see Additional file 1). To better
capture individual perceptions of the matter, we phrased
the questions using the words “according to your feel-
ings”, as these were shown to be better predictors than
those phrased as purely cognitive probability judgments
[17].
Individuals were then asked if they intended to be vac-
cinated in the next influenza season, and the major
reasons for their decisions. In addition, for each inter-
viewee, we presented ten types of IPs (Table 1), and
asked the interviewee to state for each IP, on a seven
point Likert scale, his/her tendency to get vaccinated if
the intervention program was to be applied, where 1
means ‘won’t persuade me to take the vaccination’, and 7
means ‘will definitely persuade me to take the vaccin-
ation’. The IPs were presented in a random order to pre-
vent potential bias. In 2011 several IPs had already been
implemented (see introduction). To take this effect into the
individual’s vaccination decision we assumed in our analysis
that an IP will be effective if one of two conditions wasobserved: 1) an individual declared he/she would not be
vaccinated in the upcoming season, but indicated he/she
will be willing to do so if the IP is offered; 2) an individual
declared he/she will be vaccinated in the upcoming season
because of the IP that is currently offered. We present here
results obtained under the assumption that IPs are effective
if an individual marked 6 or 7 on the Likert scale. The same
trends were found when we assumed that IPs are effective
only for a score of 7 or for a score of 5 and above on the
Likert scale (available from the authors).
Data analysis
To consider our hypothesis that risk perception towards
influenza and vaccination affects the vaccination deci-
sion differently when an IP is provided or not, we used
an ordinal regression model (using the Polytomous Uni-
versal procedure). Specifically, we divided the population
into three ordinal categories based on their behavior: 1)
Acceptors; 2) Conditional Acceptors, and; 3) Non-Acceptors.
The model is represented as follows:
ln θj
  ¼ αj−β1X1−β2X2−β3X3 j ¼ 1; 2 :
For each interviewee we evaluated risk perceptions as
the three independent variables in the model: perceived
risk reduction following vaccination, X1; perceived likeli-
hood of infection if the individual is not vaccinated, X2;
and perceived severity differences between infection and
vaccination, X3 (see questionnaire items in Table 2). β
represents the corresponding coefficient for each inde-
pendent variable. The logit, denoted ln(θj), represents
the natural logarithm of the odds for an individual in
category j or less to be vaccinated compared with
Table 2 Perceived values for the three groups








Generally speaking, what are the chances that you will contract
seasonal influenza if you do not get vaccinated in that season?
6.57 (6.24, 6.89) 5.22 (4.75,5.70) 4.16 (3.82,4.49)
Perceived risk
reduction**
a. Generally speaking, what are the chances that you will contract
seasonal influenza if you get vaccinated in that season?
3.13 (2.72,3.53) 1.61 (1.01,2.21) 0.45 (0.06, 0.83)
b. Generally speaking, what are the chances that you will contract
seasonal influenza if you do not get vaccinated in that season?
Perceived
severity**
a. Do you feel that it is dangerous for you to contract seasonal
influenza?
3.71 (3.26,4.16) 1.03 (0.42,1.64) 0.06 (−0.38,0.50)
b. Do you feel that it is dangerous for you to get influenza
vaccination?
*All questions were ranked on a 10 point Likert scale where 0 means no chance of becoming infected (no hazard at all) and 10 means definitely will become ill
(extremely high hazard).
**The perceived risk and severity reductions were computed as the difference between the two questionnaire items. The difference could be negative as several
interviewees pointed out that vaccination might be more harmful than infection.
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the threshold value for each logit.
To gain further insight into the relationship between
risk perception and vaccination behavior, we conducted
Tukey post-hoc tests for each of the three variables of risk
perception, as the dependent variables, and vaccination
decision (i.e., Acceptors, Conditional-Acceptors, and Non-
Acceptors), as the factor. Further, the Pearson correlation
was used to determine the correlations between the re-
ceptiveness of an individual to become vaccinated for
the different IPs provided.
Results
To determine vaccination uptake and examine the ef-
fectiveness of different IPs in increasing vaccination
uptake, we stratified the population into three sub-
groups: Acceptors, who receive vaccination regardless
of IPs (22%), Conditional Acceptors, who will be vaccinated
only due to implementation of IPs (44%) and Non-Accep-
tors, who are not vaccinated despite IPs (34%). Our analysis
of the ordinal regression model shows that the risk percep-
tion towards influenza relative to the risk of the vaccine is
significantly different among the three groups (P < 0.01).
Specifically, the risk perception towards influenza rela-
tive to vaccination is higher in the Acceptors than in the
Conditional Acceptors, with the Non-Acceptors showing
the lowest risk perception. This finding suggests that risk
perceptions may play an important role in understand-
ing which group is more likely to be persuaded by the
implementation of intervention programs.
For each interviewee, we evaluated the perceived se-
verity reductions by computed the difference between
his/her perceived severity of infection and the perceived
severity of vaccination (Table 2). The difference could be
negative as several interviewees pointed out that vaccin-
ation might be more harmful than infection. Likewise,we evaluated the perceived risk reductions of infection
following (Table 2). Post-hoc homogenous tests intensify
these findings, and demonstrate that these three sub-
groups are significantly different from each other in
terms of individuals’ perceived likelihood to become in-
fected with influenza (Tukey, P < 0.01), the perceived risk
reduction following vaccination (Tukey, P < 0.023), and the
perceived severity of infection compared to vaccination
(Tukey, P < 0.01) (Table 2). Moreover, among the Non-Ac-
ceptors, 41.3% (95% CI, 36.8-45.7%) declared that vaccin-
ation is more harmful than being infected with influenza.
For Conditional Acceptors, our results indicate that the
form of the IP has a moderate effect on the vaccination
decision. Namely, individuals who are more likely to be
vaccinated due to the provision of a certain IP are more
likely to be vaccinated if another IP would have been
provided instead (0.22 < r2 < 0.62, P < 0.001). In the over-
all population, we also found that physician recommen-
dations were the most effective IPs (Figure 1). The
provision of information pamphlets regarding the dis-
ease and regarding the vaccination was found as the sec-
ond most influential IP, yet not significant than the rest
of the IPs (P = 0.29).
Our analysis of the special interest sub-populations we
interviewed demonstrates that some sub-populations are
more prone to accept vaccinations (Table 3). For ex-
ample, 81% of the students who were not willing to be
vaccinated without IPs (69) would be persuaded to be
vaccinated if they received proper IPs. However, only
30% of healthcare workers would be persuaded to be
vaccinated if proper IPs were provided. If no IPs were
provided, 33.9% of the healthcare workers and only
8.1% of the students would be vaccinated. Additionally,
in line with previous studies [20], vaccination coverage
among Israeli Arabs was as high as 30% regardless of
IPs (Table 3).
Figure 1 Proportion of total population vaccinated given different intervention programs. Mean proportion and 90% confidence level for
the overall population given IPs.
Table 3 Comparison among sub-populations
Paper questionnaires Segments from the telephone survey
Sub-population Ultra-orthodox













18 N = 244
Elderly above








Age (Years) 37.3 (9.5) 36.1 (6.1) 24 (1.8) 38 (14) 39 (11) 53.7 (20.1) 63.3 (10.1) 45 (16) 49.6 (18)
Gender (percentage
female)
61.7 (5.1) 14.8 (3.9) 64 (5.1) 52 (5.3) 79 (3.8) 43.5 (3) 44.2 (3.5) 50.1 (4) 54.4 (3.6)
Categories (percentage)
Self- Acceptors 20 (4.4) 11 (3.4) 8 (3) 31(5.1) 33 (4.5) 28 (3) 19 (2.6) 24.4(3) 28.7 (3.2)
Intervention Program
vaccinators
47 (5.5) 49 (5.5) 81(4.3) 41(5.4) 30 (4.3) 40 (3.2) 44 (3.3) 31.1(3.6) 41.5 (3.5)
Non-Acceptors 33 (5.2) 4 (5.4) 11(3.4) 28(4.9) 37 (4.6) 32 (3.1) 37 (3.2) 44.5 (4.4) 29.8 (3.2)
Form of intervention programs (percentage willing to be vaccinated)
Free vaccination 16.1 (4.1) 21 (4.5) 18.8 (4.2) 9.2 (3.1) 8.3 (2.7) 7.1 (1.7) 6.3 (1.74) 3 (1.3) 7.7 (2)
Improved accessibility 21 (4.5) 25.9 (4.8) 24.7 (4.6) 12.6 (3.6) 11 (3.1) 6.7 (1.6) 4.7(1.5) 5.6 (1.8) 8.2 (2)
Vaccination as nasal
spray
13.6 (3.8) 23.5 (4.7) 22.4 (4.5) 11.5 (3.4) 11 (3.1) 6.7 (1.6) 5.7 (1.7) 7.4 (2) 7.1 (1.8)
Physician
recommendations
28.4 (5) 28.4 (5) 25.9 (4.7) 28.7 (4.9) 18.3 (3.8) 28.4 (2.9) 31.3 (3.3) 20.4 (3) 29.7(3.1)
Coupons 14.8 (3.9) 19.8 (4.4) 23.5 (4.5) 10.3 (3.3) 6.4 (2.4) 6.2 (1.5) 4.7 (1.5) 2.4 (1.2) 8.7 (2)
Telephone reminders 14.8 (3.9) 18.5 (4.3) 8.2 (2.9) 6.9 (2.7) 7.3 (2.5) 5.3 (1.4) 3.1 (1.2) 3.1 (1.3) 6.6 (1.7)
Tax if refuse 13.6 (3.8) 13.6 (3.8) 54.1 (5.3) 13.8 (3.7) 10.1 (2.9) 9.3 (1.9) 6.3 (1.7) 5.5 (1.8) 9.8 (2.1)
TV or Radio 8.6 (3.1) 9.9 (3.3) 9.4 (3.1) 11.5 (3.4) 9.2 (2.8) 7.6 (1.7) 8.3 (2) 7.5 (2.1) 8.2(2)
Information pamphlets 18.8 (4.3) 18.5 (4.3) 11.8 (3.5) 14.9 (3.8) 10.1 (2.9) 10.7 (2) 6.8 (1.8) 8.7 (2.2) 8.7(2)
Payment for
vaccination
18.5 (4.3) 21 (4.5) 42.4 (5.3) 12.6 (3.6) 6.4 (2.4) 6.2 (1.5) 6.3 (1.7) 3.1 (1.3) 9.2 (2.1)
aHigh and low incomes refer to a rank of an individual’s household salary compared to the gross median salary of households in Israel in 2012.
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or providing coupons to vaccinated individuals were more
effective than others for ultra-religious orthodox Jews and
for students; vaccinations in more accessible areas were
highly effective for the ultra-orthodox Jews, soldiers, and
medical personnel; and TV and radio advertisements were
highly effective for people above 50 years of age (Table 3).
Individuals with lower income levels were more receptive
(P = 0.025) to IPs than individuals with higher income
levels. Those with lower income levels were also more
affected by financial incentives (Table 3). Gender was not
found to affect the results.
Discussion
In line with previous studies, we showed that risk percep-
tions governed influenza vaccination decisions [14,21-23].
We further determined that risk perceptions can also help
predict whether IPs would be effective in altering vac-
cination behavior. Our findings suggest that the Israeli
population as a whole has a solid opinion on vaccin-
ation. Thus, rather than targeting the entire popula-
tion, IPs may influence best the conditional acceptors
who have an intermediate perception towards the risk.
Thus, IPs should be designed to consider the IP’s pref-
erences of this sub-population in mind.
In line with previous studies [24-26], our analysis sug-
gests that physician recommendation is the most effect-
ive intervention program in nearly all sub-groups tested.
However, this form of intervention might be more costly
for implementation. On the other hand, the provision of
information pamphlets regarding both the disease and
the vaccination is fairly cheap and highly effective. Re-
gardless of the form of intervention, our results suggest
that the socio-demographic and socio-economic diver-
sity in the Israeli population may necessitate that IPs be
customized to the preferences of each sub-population.
For example, TV advertisements should focus mainly
on the elderly, whereas vaccination centers would be
effective if provided in proximity to the habitants of
Ultra-orthodox Jews. Importantly, evaluation of the effect-
iveness of a combination of IPs could not be accurately
achieved through our survey. Future research could use
case control studies with larger number of participants than
conducted in this study to analyze the influence of com-
bined IPs on vaccination rates among each sub-population.
Former studies have shown that people tend to try to
satisfy the pollsters in survey studies [27], which for our
study would imply that the effect of IPs may be less de-
sirable than we observed. The overall declared vaccin-
ation coverage obtained through the telephone survey
was 14% higher than the actual coverage [8]. Further, risk
perceptions and attitudes regarding IPs may change over
time and should be evaluated frequently. For example, low
uptake and arguments for rejecting the A/H1N1 vaccinewere observed in 2009 in Israel [22], whereas in 2013 a
higher demand for the influenza vaccine was reported in
the beginning of the season, possibly due to increased
awareness following a successful polio vaccination cam-
paign [28].
Conclusion
In conclusion, we showed that risk perception of influenza
and vaccination governs the likelihood of successful
implementation of IPs. Our results indicate that policy
makers in Israel should invest efforts to increase the
knowledge regarding influenza and vaccination, and
apply specific interventions customized to the prefer-
ences of the diverse Israeli sub-populations.
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